Fortress Private Ledger’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,486
Closed -$279K 261
2025
Q4
$279K Buy
5,486
+1,296
+31% +$66.3K 0.09% 169
2025
Q3
$233K Buy
+4,190
New +$245K 0.08% 181
2025
Q1
Sell
-3,027
Closed -$260K 182
2024
Q4
$260K Buy
+3,027
New +$327K 0.16% 116

Other funds holding NVO

Fortress Private Ledger's NVO Position: Q1 2026 in Review

Fortress Private Ledger sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,486 shares — an estimated $279K sold.

Fortress Private Ledger first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $279K in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Fortress Private Ledger reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Fortress Private Ledger sold 5,486 Novo Nordisk shares in Q1 2026, an estimated $279K.
  • Fortress Private Ledger first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
  • Fortress Private Ledger's Novo Nordisk position peaked at $279K in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Fortress Private Ledger's 13F filing for Q1 2026, filed 13 May 2026.